Why Opioid Suits Avoid GCs — And Why That Could Change

So far, top corporate lawyers have mostly been left out of the recent wave of lawsuits against companies with possible ties to the nationwide deadly opioid drug crisis, but experts warn...

Already a subscriber? Click here to view full article